People on the Move – October 23, 2017

By Matt Skoufalos

Brenda L. Raphael

Bayer of Whippany, New Jersey has named Brenda L. Raphael SVP and GM of Therapeutics of its North American consumer health commercial operations, and Jennifer Brendel VP of communications for its U.S. consumer health division.

Raphael was most recently GM for U.S. brands at Pfizer, Inc., and has held senior positions at Coca-Cola and Procter & Gamble. She holds a University of Virginia MBA. Brendel had led Bayer pharmaceutical product communications for the past year-and-a-half.

Jennifer Brendel

Graham-Pelton Consulting Inc. of New York, New York has named Stuart P. Sullivan its SVP. Most recently, Sullivan was EVP and chief development officer for the Children's Hospital of Philadelphia; he has worked in development at Temple University and the University of Pennsylvania, his alma mater, Roanoke College; and Lynchburg College.

Stuart P. Sullivan

Acuity Healthcare of Charlotte, North Carolina has named Melissa Low CEO of Acuity Hospital of South Texas. Low had been Chief Clinical Officer of its South Texas team since June 2017. Previously, she was the director of Adult Emergency Services at Methodist Healthcare System and has held leadership roles with Baptist Health System in San Antonio.

The Fall River, Massachusetts-based Millstone Medical has added microbiologist Joshua Browning to its sterile packaging facility. Browning joins the company from Nanotherapeutics, where he was a microbiology quality control analyst; he has also worked as an R&D Analyst at NovaBone Products.

EW Healthcare Partners of New York, New York has added senior advisors Lamberto Andreotti and William A. Hawkins III. Andreotti is a former chairman and CEO of Bristol Myers Squibb, a member of the board of directors of DowDuPont Inc. and a director for the American Italian Cancer Foundation. He holds a master’s degree in science from the Massachusetts Institute of Technology. Hawkins is the former chairman and CEO of Medtronic, was formerly president and CEO of Novoste, and is chairman of the board of Bioventus. He holds an MBA from the University of Virginia, is an AIMBE Fellow and was elected to the National Academy of Engineering in 2016.

Washington-based Seattle Children's has named Suzanne Beitel its SVP and CFO. Beitel spent 20 years with JP Morgan, where she is executive director of its public finance group. She is also a board member and chair of the finance committee for Stamford Health, and has an MBA from Northwestern University.

Boston Biomedical of Cambridge, Massachusetts has named Edgar Braendle EVP, head of research and development, and Chief Medical Officer, and Dee Mahoney SVP and Chief Commercial Officer. Braendle was formerly president and CEO of ARUP Laboratories and was SVP and Global Health of Companion Diagnostics at Novartis Pharmaceutical Corporation. Mahoney was cofounder and president of DMH BioPharm Advisors, and had been SVP and GM of Pfizer's U.S. Specialty Products Business Unit.

Inova Personalized Health Accelerator of Fairfax, Virginia has named Rick Gordon its director. Gordon was a founding managing partner of MACH37, had been VP of product management at KEYW Corporation, COO of Lookingglass Cyber Solutions Inc., managing director at The Civitas Group, CEO of Tovaris, and was an technology investment banker at Bear, Stearns & Co. Gordon has an MBA from the University of Virginia and a bachelor’s degree in engineering from the U.S. Naval Academy. He is also a former submarine officer.

The Columbia, Maryland-based Foundation Fighting Blindness named Benjamin Yerxa its CEO. Yerxa most recently was president and co-founder of Envisia Therapeutics, and has been a co-founder or senior executive positions at Liquidia Technologies, Clearside Biomedical, Parion Sciences and Inspire Pharmaceuticals.

Click here if you have a person on the move you would like to share with us.